OCUL vs GOOGL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

GOOGL has stronger fundamentals based on our AI analysis.

OCUL
OCULAR THERAPEUTIX, INC
SELL
72%
Confidence
VS
GOOGL
Alphabet Inc.
BUY
91%
Confidence

OCUL vs GOOGL Fundamental Comparison

Metric OCUL GOOGL
Revenue $52.0M $402.8B
Net Income $-265.9M $132.2B
Net Margin -511.9% 32.8%
ROE -40.6% 31.8%
ROA -32.9% 22.2%
Current Ratio 15.39x 2.01x
Debt/Equity 0.04x 0.12x
EPS $-1.42 $10.81

Green = Better metric | Red = Weaker metric

View Full OCUL Analysis →
View Full GOOGL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OCUL vs AAPL GOOGL vs MSFT OCUL vs AMZN GOOGL vs NVDA

OCUL vs GOOGL: Frequently Asked Questions

Is OCUL or GOOGL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), GOOGL has stronger fundamentals. OCUL is rated SELL (72% confidence) while GOOGL is rated BUY (91% confidence). This is not investment advice.

How does OCUL compare to GOOGL fundamentally?

OCULAR THERAPEUTIX, INC has ROE of -40.6% vs Alphabet Inc.'s 31.8%. Net margins are -511.9% vs 32.8% respectively.

Which stock pays higher dividends, OCUL or GOOGL?

OCUL has a dividend yield of N/A or no dividend while GOOGL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OCUL or GOOGL for long term?

For long-term investing, consider that OCUL has SELL rating with 72% confidence, while GOOGL has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OCUL vs GOOGL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OCUL vs GOOGL, the AI consensus favors GOOGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.